Report Detail

Medical Devices & Consumables Brain Monitoring Devices Global Market

  • RnM2895578
  • |
  • 12 March, 2020
  • |
  • Global
  • |
  • 491 Pages
  • |
  • IQ4I Research & Consultancy
  • |
  • Medical Devices & Consumables

Brain monitoring is a technology including the application of different devices to image or monitor the structure, function or pharmacology of the brain. Brain monitoring techniques are segmented into structural imaging and functional imaging where structural imaging includes the diagnosis of the nervous system in a larger scale for the disorders like tumor, injury by techniques like CT and MRI. Functional imaging includes the diagnosis in a finer scale for the Alzheimer’s disease and other psychiatric behavioural disorders by devices like EEG, MEG, ICP, TCD, oximeters and PET devices. The functional imaging data provides images of the brain as patients complete tasks, such as solving math problems, reading, or responding to stimuli such as auditory sounds or flashing lights. Current brain monitoring techniques provides both form and functions of the brain like brain anatomy, integrity of the brain structures, brain’s chemistry, physiology and electrical and metabolic activity. EEG records the electrical activity associated with the neuronal depolarization and MEG records the magnetic field produced by these electrical activity.
Improvements in technology, methodology and interpretation continue to come up at an enhancing rate in the field of brain monitoring devices market. From the past decade there are tremendous progressive refinements in brain monitoring devices in terms of portability, efficiency, cost and invasive & non-invasive nature. The transitions includes from conventional, heavy room occupying EEG monitoring machines to modern portable, wireless, mobile machines with advanced computational power . The recent advancements in these devices includes a new brain monitoring device by a research team from the Perelman School of Medicine at the University of Pennsylvania that is implanted with in the brain and naturally melts away over time hence avoiding the surgical removal. This implanted device continuously sends data regarding the brain health of the patients. Electrophysiological signals were tracked for 30 days by devices located on the surface of the brain cortex and the area between the skull and scalp.
Over the years, the speed, efficacy, cost-effectiveness of brain monitoring devices have spread its usage across all clinical applications, from epilepsy, stroke, dementia, TBI and other applications to surgeries and anaesthesia and so on.
The brain monitoring devices global market is expected to grow at mid single digit CAGR to reach $10,011.5 million by 2023. Brain monitoring devices market is mainly classified into products, application and end-users.
The product classification consists of electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, transcranial Doppler sonography (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices and accessories. The electroencephalography devices market is further segmented into by product type which includes 8-channel, 21-channel, 25-channel, 32-channel, 40-channel and multi-channel and by modality includes standalone/fixed EEG devices and portable EEG devices. The magnetic resonance imaging is divided based upon technology into low and middle field MRI, high field MRI and very high field MRI. Finally computed tomography devices is further classified into low slice CT, medium slice CT and high slice CT depending on the technology.
The global brain monitoring devices market by application is segmented into neurodegenerative disorders, brain tumor, sleep disorders, psychiatric behavioural disorders and other applications. The neurodegenerative disorders is sub segmented into epilepsy, Parkinson’s disease, Huntington’s disease, stroke, traumatic brain injury (TBI) and dementia whereas sleep disorders is sub classified into sleep apnea, insomnia, hypersomnia and sleep movement disorders. Psychiatric behavioural disorders are sub divided into autism, schizophrenia, dyslexia, bipolar disorders and depression. Other application is sub segmented into surgery, headache disorders, anesthesia and hydrocephalus.
The end-users of brain monitoring devices market are hospitals, home care, ambulatory surgical centers and clinics, diagnostic centers and other end users.
Among the devices market, the sleep monitoring devices segment dominated the market by occupying a largest share and cerebral oximeters market is the fastest growing segment from 2016 to 2023. Likewise, under applications section neurodegenerative disorders segment holds the largest share and also the fastest growing segment from 2016 to 2023. By end-users, hospital is the largest segment and is the fastest segment growing segment from 2016 to 2023. Geographical wise, North America is the largest market share followed by Europe, Asia-Pacific and Rest of the World. The Asia region is the fastest growing region from 2016 to 2023 suggesting an array of opportunities for growth and likely to be getting into the eyes of new investors in the brain monitoring devices market. Growth in the Asian market is attributed to rising prevalence of neurological diseases, government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The brain monitoring devices global market is expected to grow at mid single digit CAGR from 2016 to 2023. The factors driving the growth of this market are growing incidence and prevalence of neurological disorders, rising awareness about neurodegenerative disorders, technological advancements/innovations offering wider scope of application for brain monitoring devices and growing healthcare spending.
While increasing focus on minimally invasive brain monitoring procedure and extended application of devices in clinical trials are some of the opportunities that are propelling the growth of the market. However shortage of trained professionals, high cost of complex devices, unfavourable reimbursement policies, stringent regulatory guidelines and competition from local players in emerging markets are hampering the growth of the market.
The brain monitoring devices global market is a fragmented market whereas each product devices is highly consolidated and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the brain monitoring devices market are Advanced Brain Monitoring (U.S.), Cadwell laboratories (U.S.), CAS Medicals Inc.(U.S), Compumedics Limited (Australia), Electrical Geodesics Incorporated (U.S.), Elekta AB (Sweden), GE Healthcare (U.S.), Integra Lifesciences (U.S.), Koninklijke Philips N.V. (Netherland), Masimo corporation (U.S.), Medtronic (Ireland), Natus Medical Inc.(U.S.), Nihon Kohden Corporation (Japan) and Siemens Healthineers (Germany).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)


1 EXCEUTIVE SUMMARY 33

    2 INTRODUCTION 50

    • 2.1 KEY TAKE AWAYS 50
    • 2.2 REPORT DESCRIPTION 51
    • 2.3 MARKETS COVERED 54
    • 2.4 STAKEHOLDERS 57
    • 2.5 RESEARCH METHODOLOGY 57
      • 2.5.1 MARKET SIZE ESTIMATION 58
      • 2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 61
      • 2.5.3 SECONDARY SOURCES 62
      • 2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES 63
      • 2.5.5 PRIMARY SOURCES 64
      • 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 64
      • 2.5.7 ASSUMPTIONS 64

    3 MARKET ANALYSIS 66

    • 3.1 INTRODUCTION 66
    • 3.2 MARKET SEGMENTATION 67
    • 3.3 FACTORS INFLUENCING MARKET 69
      • 3.3.1 DRIVERS AND OPPORTUNITIES 70
        • 3.3.1.1 Growing incidence and prevalence of neurological disorders 70
        • 3.3.1.2 Rising awareness about neurodegenerative disorders 71
        • 3.3.1.3 Growing healthcare spending 72
        • 3.3.1.4 Technological advancements/innovations offering wider scope of

      applications for brain monitoring 73

      • 3.3.1.5 Increasing focus on minimally invasive brain activity monitoring

    procedures 75

    • 3.3.1.6 Extended application of devices in clinical trials 76
  • 3.3.2 RESTRAINTS & THREATS 77
    • 3.3.2.1 High cost of complex devices 77
    • 3.3.2.2 Lack of skilled neurologists 78
    • 3.3.2.3 Stringent regulations and legislations guiding the brain monitoring device
  • manufacturers 79

    • 3.3.2.4 Unfavorable Reimbursement policies 79
  • 3.4 PORTER’S FIVE FORCE ANALYSIS 81
    • 3.4.1 THREAT OF NEW ENTRANTS 82
    • 3.4.2 THREAT OF SUBSTITUTES 82
    • 3.4.3 RIVALRY AMONG EXISTING COMPETITORS 83
    • 3.4.4 BARGAINING POWER OF SUPPLIERS 83
    • 3.4.5 BARGAINING POWER OF BUYERS 84
  • 3.5 REGULATORY GUIDELINES 84
    • 3.5.1 UNITED STATES 85
    • 3.5.2 EUROPE 86
    • 3.5.3 JAPAN 87
    • 3.5.4 INDIA 88
    • 3.5.5 CHINA 89
  • 3.6 REIMBURSEMENT SCENARIO 90
    • 3.6.1 REIMBURSEMENT TABLE 92
  • 3.7 PATENT TRENDS 98
  • 3.8 SUPPLY CHAIN ANALYSIS 100
  • 3.9 BRAIN MONITORING DEVICES NUMBER OF UNITS 102
  • 3.10 BRAIN MONITORING DEVICES UNDER CLINICAL TRIAL 106
  • 3.11 RECENT TECHNIQUES BASED-ON APPLICATION 109
  • 3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 112
  • 3.13 INDIVIDUAL BRAIN MONITORING DEVICES MARKET SHARE ANALYSIS BY
  • MAJOR PLAYERS 115

    • 3.14 TECHNOLOGICAL ADVANCEMENT 123
      • 3.14.1 DISSOLVABLE BRAIN IMPLANTS 123
      • 3.14.2 DIFFUSED OPTICAL TOMOGRAPHY (DOT) 124
      • 3.14.3 EAR ELECTROENCEPHALOGRAPHY (EAR-EEG) 124
      • 3.14.4 PORTABLE EEG DEVICES 125
      • 3.14.5 BRAIN TISSUE OXYGEN TENSION MONITORS 126
      • 3.14.6 WIRELESS HELMET 126

    4 BRAIN MONITORING DEVICES GLOBAL MARKET, BY PRODUCTS 128

    • 4.1 INTRODUCTION 128
    • 4.2 ELECTROENCEPHALOGRAPHY (EEG) DEVICES 131
      • 4.2.1 BY PRODUCT TYPE 133
        • 4.2.1.1 8-Channel EEG 135
        • 4.2.1.2 21-Channel EEG 136
        • 4.2.1.3 25-Channel EEG 138
        • 4.2.1.4 32-Channel EEG 139
        • 4.2.1.5 40-Channel EEG 140
        • 4.2.1.6 Multi-Channel EEG 141
      • 4.2.2 BY MODALITY 142
        • 4.2.2.1 Standalone or Fixed Electroencephalography 145
        • 4.2.2.2 Portable Electroencephalography 146
    • 4.3 MAGNETOENCEPHALOGRAPHY (MEG) DEVICES 148
    • 4.4 INTRACRANIAL PRESSURE (ICP) MONITORS 151
    • 4.5 TRANSCRANIAL DOPPLER SONOGRAPHY DEVICES 153
    • 4.6 CEREBRAL OXIMETERS 155
    • 4.7 MAGNETIC RESONANCE IMAGING (MRI) DEVICES 157
      • 4.7.1 BY TECHNOLOGY 160
        • 4.7.1.1 Low and Middle Field MRI 162
        • 4.7.1.2 High Field MRI 163
        • 4.7.1.3 Very High Field MRI 164
    • 4.8 COMPUTERIZED TOMOGRAPHY (CT) DEVICES 166
      • 4.8.1 BY TECHNOLOGY 167
        • 4.8.1.1 Low Slice CT 169
        • 4.8.1.2 MEDIUM SLICE CT 170
        • 4.8.1.3 High Slice CT 172
    • 4.9 POSITRON EMISSION TOMOGRAPHY (PET) DEVICES 173
    • 4.10 SLEEP MONITORING DEVICES 176
    • 4.11 BY ACCESSORIES 178

    5 BRAIN MONITORING DEVICES GLOBAL MARKET, BY APPLICATIONS 188

    • 5.1 INTRODUCTION 188
    • 5.2 NEURODEGENERATIVE DISORDERS 190
      • 5.2.1 EPILEPSY 194
      • 5.2.2 PARKINSON’S DISEASE 197
      • 5.2.3 HUNTINGTON’S DISEASE 199
      • 5.2.4 STROKE 201
      • 5.2.5 TRAUMATIC BRAIN INJURY (TBI) 203
      • 5.2.6 DEMENTIA 206
    • 5.3 BRAIN TUMOR 208
    • 5.4 SLEEP DISORDERS 211
      • 5.4.1 INSOMNIA 215
      • 5.4.2 HYPERSOMNIA 217
      • 5.4.3 SLEEP APNEA 219
      • 5.4.4 SLEEP MOVEMENT DISORDERS 221
    • 5.5 PSYCHIATRIC BEHAVIORAL DISORDERS 223
      • 5.5.1 AUTISM 226
      • 5.5.2 SCHIZOPHRENIA 229
      • 5.5.3 DYSLEXIA 231
      • 5.5.4 DEPRESSION 232
      • 5.5.5 BIPOLAR DISORDERS 234
    • 5.6 OTHER APPLICATIONS 236
      • 5.6.1 SURGERY 239
      • 5.6.2 ANESTHESIA 241
      • 5.6.3 HYDROCEPHALUS 243
      • 5.6.4 HEADACHE DISORDERS 245

    6 BRAIN MONITORING DEVICES GLOBAL MARKET, BY END-USERS 248

    • 6.1 INTRODUCTION 248
    • 6.2 HOSPITALS 251
    • 6.3 HOME CARE 253
    • 6.4 AMBULATORY SURGICAL CENTERS AND CLINICS 254
    • 6.5 DIAGNOSTIC LABORATORIES 257
    • 6.6 OTHER END-USERS 258

    7 REGIONAL ANALYSIS 262

    • 7.1 INTRODUCTION 262
    • 7.2 NORTH AMERICA 264
      • 7.2.1 UNITED STATES 278
      • 7.2.2 OTHERS 281
    • 7.3 EUROPE 287
      • 7.3.1 GERMANY 300
      • 7.3.2 FRANCE 303
      • 7.3.3 UNITED KINGDOM 305
      • 7.3.4 OTHERS 308
    • 7.4 ASIA-PACIFIC 312
      • 7.4.1 JAPAN 325
      • 7.4.2 CHINA 329
      • 7.4.3 INDIA 332
      • 7.4.4 OTHERS 335
    • 7.5 REST OF THE WORLD 339
      • 7.5.1 BRAZIL 351
      • 7.5.2 REST OF LATIN AMERICA 354
      • 7.5.3 MIDDLE EAST AND OTHERS 357

    8 COMPETITIVE LANDSCAPE 360

    • 8.1 INTRODUCTION 360
    • 8.2 NEW PRODUCT LAUNCHES 361
    • 8.3 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES 368
    • 8.4 APPROVALS 375
    • 8.5 MERGERS & ACQUISITIONS 378
    • 8.6 OTHER DEVELOPMENTS 380

    9 MAJOR COMPANIES 383

    • 9.1 ADVANCED BRAIN MONITORING 383
      • 9.1.1 OVERVIEW 383
      • 9.1.2 FINANCIALS 383
      • 9.1.3 PRODUCT PORTFOLIO 384
      • 9.1.4 KEY DEVELOPMENTS 385
      • 9.1.5 BUSINESS STRATEGY 386
      • 9.1.6 SWOT ANALYSIS 388
    • 9.2 CADWELL INDUSTRIES INC. 389
      • 9.2.1 OVERVIEW 389
      • 9.2.2 FINANCIALS 389
      • 9.2.3 PRODUCT PORTFOLIO 389
      • 9.2.4 KEY DEVELOPMENTS 390
      • 9.2.5 BUSINESS STRATEGY 390
      • 9.2.6 SWOT ANALYSIS 391
    • 9.3 CAS MEDICAL SYSTEMS INC 392
      • 9.3.1 OVERVIEW 392
      • 9.3.2 FINANCIALS 393
      • 9.3.3 PRODUCT portfolio 396
      • 9.3.4 KEY DEVELOPMENTS 397
      • 9.3.5 BUSINESS STRATEGY 399
      • 9.3.6 SWOT ANALYSIS 400
    • 9.4 COMPUMEDICS LIMITED 401
      • 9.4.1 OVERVIEW 401
      • 9.4.2 FINANCIALS 402
      • 9.4.3 PRODUCT PORTFOLIO 403
      • 9.4.4 KEY DEVELOPMENTS 405
      • 9.4.5 BUSINESS STRATEGY 408
      • 9.4.6 SWOT ANALYSIS 409
    • 9.5 ELEKTA AB 410
      • 9.5.1 OVERVIEW 410
      • 9.5.2 FINANCIALS 411
      • 9.5.3 PRODUCT PORTFOLIO 413
      • 9.5.4 KEY DEVELOPMENTS 414
      • 9.5.5 BUSINESS STRATEGY 414
      • 9.5.6 SWOT ANALYSIS 415
    • 9.6 ELECTRICAL GEODESICS, INC 416
      • 9.6.1 OVERVIEW 416
      • 9.6.2 FINANCIALS 417
      • 9.6.3 PRODUCT PORTFOLIO 419
      • 9.6.4 KEY DEVELOPMENTS 421
      • 9.6.5 BUSINESS STRATEGY 423
      • 9.6.6 SWOT ANALYSIS 424
    • 9.7 GE HEALTHCARE 425
      • 9.7.1 OVERVIEW 425
      • 9.7.2 FINANCIALS 426
      • 9.7.3 PRODUCT PORTFOLIO 428
      • 9.7.4 KEY DEVELOPMENTS 430
      • 9.7.5 BUSINESS STRATEGY 431
      • 9.7.6 SWOT ANALYSIS 432
    • 9.8 INTEGRA LIFE SCIENCES 433
      • 9.8.1 OVERVIEW 433
      • 9.8.2 FINANCIALS 434
      • 9.8.3 PRODUCT PORTFOLIO 436
      • 9.8.4 KEY DEVELOPMENTS 439
      • 9.8.5 BUSINESS STRATEGY 439
      • 9.8.6 SWOT ANALYSIS 440
    • 9.9 KONINKLIJKE PHILIPS N.V. 441
      • 9.9.1 OVERVIEW 441
      • 9.9.2 FINANCIALS 442
      • 9.9.3 PRODUCT PORTFOLIO 444
      • 9.9.4 KEY DEVELOPMENTS 446
      • 9.9.5 BUSINESS STRATEGY 447
      • 9.9.6 SWOT ANALYSIS 448
    • 9.10 MASIMO CORPORATION 449
      • 9.10.1 OVERVIEW 449
      • 9.10.2 FINANCIALS 450
      • 9.10.3 PRODUCT PORTFOLIO 451
      • 9.10.4 KEY DEVELOPMENTS 452
      • 9.10.5 BUSINESS STRATEGY 453
      • 9.10.6 SWOT ANALYSIS 454
    • 9.11 MEDTRONIC, PLC 455
      • 9.11.1 OVERVIEW 455
      • 9.11.2 FINANCIALS 456
      • 9.11.3 PRODUCT PORTFOLIO 459
      • 9.11.4 KEY DEVELOPMENTS 461
      • 9.11.5 BUSINESS STRATEGY 462
      • 9.11.6 SWOT ANALYSIS 463
    • 9.12 NATUS MEDICAL INCORPORATED 464
      • 9.12.1 OVERVIEW 464
      • 9.12.2 FINANCIALS 465
      • 9.12.3 PRODUCT PORTFOLIO 467
      • 9.12.4 KEY DEVELOPMENTS 470
      • 9.12.5 BUSINESS STRATEGY 471
      • 9.12.6 SWOT ANALYSIS 472
    • 9.13 NIHON KOHDEN CORPORATION 473
      • 9.13.1 OVERVIEW 473
      • 9.13.2 FINANCIALS 474
      • 9.13.3 PRODUCT PORTFOLIO 476
      • 9.13.4 KEY DEVELOPMENTS 477
      • 9.13.5 BUSINESS STRATEGY 479
      • 9.13.6 SWOT ANALYSIS 480
    • 9.14 SIEMENS AG 481
      • 9.14.1 OVERVIEW 481
      • 9.14.2 FINANCIALS 482
      • 9.14.3 PRODUCT PORTFOLIO 485
      • 9.14.4 KEY DEVELOPMENTS 486
      • 9.14.5 BUSINESS STRATEGY 488

    Summary:
    Get latest Market Research Reports on Brain Monitoring Devices . Industry analysis & Market Report on Brain Monitoring Devices is a syndicated market report, published as Brain Monitoring Devices Global Market . It is complete Research Study and Industry Analysis of Brain Monitoring Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,950.00
    $6,750.00
    $9,000.00
    3,717.45
    5,069.25
    6,759.00
    4,435.20
    6,048.00
    8,064.00
    712,503.00
    971,595.00
    1,295,460.00
    413,671.50
    564,097.50
    752,130.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report